Last updated on September 2017

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population.


Brief description of study

The main objective of the proposed non-interventional study is to obtain real-world effectiveness, safety and treatment patterns data of patients with BRCAm+ (Breast Cancer Gene(s) mutation positive) platinum sensitive relapsed (PSR) ovarian cancer in German hospitals and outpatient practices treated with olaparib.

Clinical Study Identifier: NCT02503436

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

AstraZeneca Clinical Study Information Center

Research Site
Brandenburg an der Havel, Germany
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Esslingen am Neckar, Germany
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Freiburg im Breisgau, Germany
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Georgsmarienhuette, Germany
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Heidenheim an der Brenz, Germany
  Connect »

AstraZeneca Clinical Study Information Center

Research Site
Moenchengladbach, Germany
  Connect »